SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-20-007390
Filing Date
2020-06-09
Accepted
2020-06-09 16:30:40
Documents
8
Period of Report
2020-08-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20200804xpre14a.htm PRE 14A 1109543
3 GRAPHIC tmb-20200804xcoverg001.jpg GRAPHIC 20191
4 GRAPHIC tmb-20200804xpre14ag001.jpg GRAPHIC 2576
5 GRAPHIC tmb-20200804xpre14ag002.jpg GRAPHIC 4250
6 GRAPHIC tmb-20200804xpre14ag003.gif GRAPHIC 119177
7 GRAPHIC tmb-20200804xpre14ag004.gif GRAPHIC 85203
8 GRAPHIC tmb-20200804xpre14ag005.gif GRAPHIC 109363
9 GRAPHIC tmb-20200804xpre14ag006.gif GRAPHIC 103814
  Complete submission text file 0001558370-20-007390.txt   1724014
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37350 | Film No.: 20952162
SIC: 3841 Surgical & Medical Instruments & Apparatus